Enhancement of the anti-inflammatory action of hydrocortisone by estrogen.
D015065:17-Hydroxycorticosteroids / Q000097:blood; D000328:Adult; D000368:Aged; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003872:Dermatitis / Q000188:drug therapy*; D004357:Drug Synergism; D004485:Eczema / Q000188:drug therapy*; D004893:Erythema Nodosum / Q000188:drug therapy*; D005260:Female; D006099:Granuloma / Q000517:prevention & control; D006168:Guinea Pigs; D006589:Hexestrol / Q000627:therapeutic use*; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use*; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000188:drug therapy*; D010392:Pemphigus / Q000188:drug therapy*; D011565:Psoriasis / Q000188:drug therapy*; D014156:Transcortin
D015065:17-Hydroxycorticosteroids; D000893:Anti-Inflammatory Agents; D006589:Hexestrol; D014156:Transcortin; D006854:Hydrocortisone